Boundless Bio
BOLD----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Boundless Bio(BOLD) predict that the EBIT is -14.48 M (+16.53%), Beat estimate;the EPS is -0.6 (+15.49%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B16.53%
-0.01B15.61%
+0.00B0.92%
EPSMiss expectations
-0.615.49%
-0.5621.13%
-0.04005.64%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf